Search results
Results From The WOW.Com Content Network
Transcriptomics technologies provide a broad account of which cellular processes are active and which are dormant. A major challenge in molecular biology is to understand how a single genome gives rise to a variety of cells. Another is how gene expression is regulated. The first attempts to study whole transcriptomes began in the early 1990s.
In November 2018, a Delaware jury found that 10x Genomics infringed on several University of Chicago patents which were exclusively licensed to Bio-Rad. 10x Genomics were ordered to pay $24 million in damages to Bio-Rad and a 15% royalty on sales. [13] [14] 10x Genomics appealed the verdict but the decision was upheld in August 2020.
Transcriptomics is an emerging and continually growing field in biomarker discovery for use in assessing the safety of drugs or chemical risk assessment. [ 33 ] Transcriptomes may also be used to infer phylogenetic relationships among individuals or to detect evolutionary patterns of transcriptome conservation.
California-headquartered life sciences company Bionano Genomics (NASDAQ:BNGO) focuses on advancing genome mapping technology. Emerging scientific fields are often risky bets, so there’s no real ...
High-throughput next-generation sequencing has become a popular technique in transcriptomics, which represent a snapshot of gene expression. In eukaryotes, making phylogenetic inferences using RNA is complicated by alternative splicing, which produces multiple transcripts from a single gene.
According to the CEO of Complete Genomics Cliff Reid, the total market for whole human genome sequencing around the world has increased five-fold during 2009 and 2010, and was estimated to be 15,000 genomes for 2011. Furthermore, if the price were to fall to $1,000 per genome, he maintained that the company would still be able to make a profit.
Genome informatics dealing with [6] microbial and metagenomics, sequencing algorithms, variant discovery and genome assembly, evolution, complex traits and phylogenetics, personal and medical genomics, transcriptomics, genome structure and function. [6]
BioNano Genomics (BNGO) is a life sciences instrumentation company for genomics analysis. The main value for BNGO comes from developing and selling its Saphyr system.